Transmedics
TMDX
432 hedge funds and large institutions have $4.53B invested in Transmedics in 2025 Q4 according to their latest regulatory filings, with 89 funds opening new positions, 155 increasing their positions, 129 reducing their positions, and 45 closing their positions.
98% more first-time investments, than exits
New positions opened: 89 | Existing positions closed: 45
68% more call options, than puts
Call options by funds: $98.1M | Put options by funds: $58.2M
26% more capital inflows, than outflows
Capital inflows: $435M | Capital outflows: $344M
20% more repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 129
10% more funds holding
Funds holding: 391 → 432 (+41)
0.21% less ownership
Funds ownership: 109.07% → 108.86% (-0.21%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$32.9M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.6M |
| 4 |
Morgan Stanley
New York
|
+$15.1M |
| 5 |
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$13.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$44.1M |
| 2 |
Two Sigma Investments
New York
|
-$25M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$24.7M |
| 4 |
Brown Capital Management
Baltimore,
Maryland
|
-$21.1M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$17M |
TMDX Hedge Fund Activity: Q4 2025 in Review
432 of the 8,317 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q4 2025, worth a combined $4.53B — up 8.5% from $4.17B a quarter earlier.
Buyers outnumbered sellers: 89 funds opened new TMDX positions and 45 closed out — a net gain of 44 holders — while 155 added to existing stakes and 129 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $32.9M. The largest seller was Marshall Wace, cutting an estimated $44.1M.
- 432 institutional investors held Transmedics (TMDX) as of Q4 2025, up from 391 in Q3 2025.
- Funds reported $4.53B of Transmedics stock for Q4 2025, up 8.5% quarter-over-quarter.
- 89 funds opened new Transmedics positions in Q4 2025 and 45 closed out, a net change of +44 holders.
- The largest Transmedics buyer in Q4 2025 was Goldman Sachs, an estimated $32.9M added.
- The largest Transmedics seller in Q4 2025 was Marshall Wace, an estimated $44.1M sold.
Based on aggregated 13F filings for Q4 2025.